Subscribe to RSS - ResMed


ResMed posts ‘solid’ fiscal year results


SAN DIEGO – ResMed officials, during an earnings call Aug. 2, downplayed competitive bidding and a new re-supply rule, saying neither would have much impact on the company.

ResMed buys compliance tool


SAN DIEGO – ResMed announced today that it has acquired Umbian, developer of U-Sleep, a software program that allows HME providers to obtain and manage compliance data from any major CPAP device.

In brief: Stakeholders organize, OIG investigates


WASHINGTON – Industry stakeholders last week submitted comments to CMS outlining concerns with a recent wave of claims against surety bonds—some triggered by overpayments as low as $16. The stakeholder, which include the Wayne van Halem Group, U.S.

In brief: Bill to repeal device tax gains ground, OMB seeks comments on PMD demo


WASHINGTON – A bill to repeal a 2.3% tax on medical devices cleared the Ways and Means Committee in the House of Representatives last week, but industry stakeholders aren’t getting their hopes up.

In brief: F&P boosts profits, ResMed launches in Japan


AUCKLAND, New Zealand – Fisher & Paykel Healthcare says expanding clinical applications for its medical devices and new products contributed to record operating revenue of NZ$516.7 million for the year ended March 31, 2012.

Home sleep therapy market starts to grow up


At some point a young, growing business market will reach maturity—it is inevitable. Whether this is the case with home sleep therapy remains to be seen, but signs are pointing in that direction.

ResMed details progress on new CEO, initiates dividend


SAN DIEGO – Dr. Pete Farrell will remain CEO of ResMed until the end of the calendar year 2013, per the request of the manufacturer’s board of directors.

In the meantime, ResMed will continue to evaluate potential internal CEO candidates.

Invacare briefs shareholders on FDA, earnings

Also: ResMed reports double-digit growth

ELYRIA, Ohio – Invacare expects to engage a third-party to audit its compliance with U.S. Food and Drug Administration (FDA) regulations in the fourth quarter of this year, company officials said during a conference call this week to discuss first quarter earnings.

Miss ResMed's earnings conference call yesterday? I didn't!

Friday, January 27, 2012

We don't always have the time (or, honestly, the wherewithal) to listen to every earnings conference call by every public company in the HME industry. But when we do, it's almost always worthwhile.

Joe Lewarski knows how to keep a secret; Invacare reaches out to clinical and academic communities

Thursday, March 25, 2010

I had a long conversation with Joe Lewarski yesterday on how important it is for respiratory therapists to titrate patients to their oxygen delivery equipment—both conservers and concentrators.